https://sentinelinitiative.org/news-events/meetings-workshops-trainings/34th-international-conference-pharmacoepidemiology-and
34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Sentinel Initiative Events
08/21/2018
Sentinel Initiative Events
08/21/2018
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/36th-international-conference-pharmacoepidemiology-and
36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Publications and Presentations
09/16/2020
Publications and Presentations
09/16/2020
https://sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-food-and
A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System Publications and Presentations
04/18/2021
Publications and Presentations
04/18/2021
https://sentinelinitiative.org/news-events/publications-presentations/strategies-use-real-world-data-conduct-covid-19-related
Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology Publications and Presentations
08/25/2021
Publications and Presentations
08/25/2021
https://sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools
09/24/2021
Methods, Data, & Tools
09/24/2021
https://sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroids-covid-19-us-outpatient-settings
Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz
Zarxio (Filgrastim-sndz) & Signal Identification Studies
06/01/2023
Studies
06/01/2023
https://sentinelinitiative.org/news-events/publications-presentations/treatment-and-care-received-children-hospitalized-covid-19
Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021 Publications and Presentations
07/11/2023
Publications and Presentations
07/11/2023
https://sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us
High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network Publications and Presentations
08/25/2023
Publications and Presentations
08/25/2023
https://sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles
Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic Publications and Presentations
08/27/2023
Publications and Presentations
08/27/2023
https://sentinelinitiative.org/studies/drugs/ozempic-semaglutide
Ozempic (Semaglutide) & Signal Identification Studies
10/25/2023
Studies
10/25/2023
https://sentinelinitiative.org/news-events/publications-presentations/validity-inpatient-electronic-health-record-based-measures
Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints Publications and Presentations
04/02/2024
Publications and Presentations
04/02/2024
https://sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp
Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies
07/17/2024
Studies
07/17/2024
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-inpatient-electronic-health-records-ehr-large
Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal
Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis Analyses
09/17/2024
Analyses
09/17/2024
https://sentinelinitiative.org/studies/drugs/aldactone-spironolactone
Aldactone (spironolactone) & Indications for Use Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal-0
Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis Analyses
11/01/2024
Analyses
11/01/2024
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system
Sentinel Routine Querying System Methods, Data, & Tools
04/01/2025
Methods, Data, & Tools
04/01/2025
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool
Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools
04/01/2025
Methods, Data, & Tools
04/01/2025
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/prescriptions-and-dispensings-central-nervous-system-cns
Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis Analyses
05/06/2025
Analyses
05/06/2025
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2022-first
Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis Analyses
05/06/2025
Analyses
05/06/2025